Prevalence and prognostic implication Of BCR/ABL fusion gene expression & JAK2 overexpression In Egyptian acute myeloid leukemia patients / Lamiaa Abdelfattah Fathalla Ahmed ; Supervised Basma Mostafa Mohammed Elgamal , Naglaa Mostafa Hassan Ahmed , Omnia Kamal Elgebaly
Material type:
- فى مرض سرطان الدم الميلودى الحاد فى المصريين و علاقتهم بالتنبؤ المرضى لديهم JAK2 و زيادة تعبير ال BCR/ABL دراسة نسبة انتشار جين ال [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.03.Ph.D.2019.La.P (Browse shelf(Opens below)) | Not for loan | 01010110079188000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.03.Ph.D.2019.La.P (Browse shelf(Opens below)) | 79188.CD | Not for loan | 01020110079188000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology
Background: Acute myeloid leukemia (AML) is a heterogenous disease with multiple established prognostic factors. JAK2 overexpression in AML was confirmed by many authors with an influence on the overall survival. Philadelphia positive AML (Ph+ AML) is a provisional entity in the recent WHO classification where discrimination from acute blastic crisis on top of chronic myeloid leukemia (CML) is still a challenge. Aims: to study JAK2 gene expression pattern in AML patients and its relation with other established prognostic variables and outcome parameters. Also, to determine the prevalence of the BCR-ABL fusion gene in AML cases with determination of the clinical and laboratory criteria of these cases. Methods: Prospective study on 175 AML patients treated at medical and pediatric oncology departments. Jak2 gene expression was evaluated by real time RT-PCR using taqman primer probe assay and BCR/ABL fusion was tested by conventional RT-PCR. All patients received current standard of care treatment for AML at NCI, Cairo University, Egypt
Issued also as CD
There are no comments on this title.